Canntab Therapeutics Limited
Canntab Therapeutics Limited (CTABF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CTABF · as of Jun 9, 2026
Key Statistics
Explore Canntab Therapeutics Limited Data
ctabf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
ctabf competitorsCTABF
CNGGF
CPIVF
LIFD
NRPR
RNVAStock Performance
Full HistoryAbout Canntab Therapeutics Limited
Canntab Therapeutics Limited is a Canadian phytopharmaceutical firm dedicated to pioneering the research and development of sophisticated, pharmaceutical-grade cannabinoid preparations. The company ma…
what is canntab therapeutics limited · ctabf stock overview · canntab therapeutics limited company profile · who is canntab therapeutics limited ceo · ctabf OTC · canntab therapeutics limited headquarters · canntab therapeutics limited business segments
About Stock Overview & Key Data
Canntab Therapeutics Limited (CTABF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Nov 28, 2017. As of the latest trading session, CTABF stock price is $0.00, with a market capitalization of $3,891. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
In fiscal year 2022, Canntab Therapeutics Limited reported revenue of $293362.00. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Canntab Therapeutics Limited (CTABF) stock price is $0.00. The stock is traded on OTC under the ticker symbol CTABF. The 52-week range is $0.00 – $0.01.